autologous dc-vaccines
Vaccineexperimental
Clinical trial activity
4 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2015 (NCT03119025)
Timeline
Indications
Mechanism of action
- Tumor antigensImmunity, active
immunity, active - tumor antigens
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- autologous dc-vaccines
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04157127 | Phase 1 | Jan 31, 2020 | Baylor University, Cancer Cures for Kids |
| NCT04166006 | Phase 2 | Dec 31, 2019 | Istituto Nazionale per lo Studio e la Cura dei Tumori |
| NCT03226236 | Phase 2 | Mar 31, 2016 | Istituto Nazionale per lo Studio e la Cura dei Tumori |
| NCT03119025 | Phase 1/Phase 2 (Phase 2) | May 1, 2015 | Russian Academy of Medical Sciences |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Istituto Nazionale per lo Studio e la Cura dei Tumori | Academic/Hospital | 2 | 2 | 1 | 2016 |
| Baylor University | Academic/Hospital | 1 | 1 | 1 | 2020 |
| Cancer Cures for Kids | Academic/Hospital | 1 | 0 | 1 | 2020 |
| Russian Academy of Medical Sciences | Academic/Hospital | 1 | 1 | 1 | 2015 |
4 organizations
Page 1 / 1